Masimo (NSDQ:MASI) announced today that its study of the Masimo Patient SafetyNet and rainbow acoustic monitoring (RAM) with RRa revealed that use of monitoring systems might provide a safety net for postoperative patients. Irvine, Calif.-based Masimo’s Patient SafetyNet is a supplemental remote monitoring patient surveillance and clinician notification system designed to work with Masimo and third-party […]
Stent makers point to quality-of-life findings by massive federal study
The giant federal study that found the use of stents in stable heart-disease patients is no better than drugs to treat clogged arteries reached another, less-hyped conclusion. Manufacturers of stents for percutaneous coronary intervention (PCI) note that the Ischemia study also concluded that patients who undergo a stenting procedure have a better quality of life. They suffer […]
Mologic launches clinical trial for COPD exacerbation alert system
Mologic announced today that it launched a clinical trial for its Headstart system for detecting exacerbations in patients living with moderate to severe chronic obstructive pulmonary disease. Headstart is an in vitro diagnostic self-test designed to detect five biomarkers that signal infection and inflammation in the urine of patients with COPD. The system integrates a […]
Study: Stents no better than drugs for stable heart disease
This article has been updated with stock market results and comments from Medtronic. A major new study has concluded that the use of stents in stable heart disease patients is no better than drugs to treat clogged arteries. Results of the Ischemia study were released at the American Heart Association annual meeting in Philadelphia on Saturday. The […]
Study: Apple Watch can identify heart rhythm irregularities
Results from a new study observed that wearable technology such as an Apple Watch can safely identify heart rate irregularities that were eventually confirmed to be atrial fibrillation. The study, conducted by the Stanford University School of Medicine and Apple (NSDQ:AAPL) was published in the New England Journal of Medicine today. The Apple Heart Study has […]
InCarda Therapeutics raises $35 million
InCarda Therapeutics — which is developing an inhaled paroxysmal atrial fibrillation drug — filed an SEC Form D confirming the sale of more than $35 million in equity. The Newark, Calif.–based drug-device combo company sold nearly $35.3 million since the first sale of the offering occurred on Oct. 20, 2017, according to yesterday’s filing. InCarda […]
Spineology touts outcome of U.S. clinical trial for interbody fusion
Spineology announced that 24-month outcomes from its Scout clinical trial for interbody fusion revealed substantial improvements in scores for low back pain and functional limitations. The Scout trial was conducted under an FDA-approved investigational device exemption protocol to evaluate safety and effectiveness outcomes in instrumented lumbar interbody fusion procedures for treating degenerative disc disease. Spineology […]
Neural Analytics launches feasibility study for Lucid robot-assisted stroke device
Neural Analytics said yesterday that it has enrolled the first subjects in a study of its Lucid robotic system for the management of patients suspected of suffering a stroke. The Codex study is a prospective, single-arm, multi-center, safety and technical feasibility study under an FDA investigational device exemption for the Lucid system. Dr. Ifeanyi Iwuchukwu […]
New study questions race, poverty as risk factors in knee surgeries
A new study observing the risk of total knee replacement revision or failure at a high-volume orthopedic hospital found that race and poverty were not significant factors in risk for knee replacement surgeries. Previous studies established that black patients have a higher risk for knee replacement revision and also report more pain and worse joint […]
Hancock Jaffe touts 6-month results for VenoValve
Hancock Jaffe Laboratories (NSDQ:HJLI) said yesterday that six-month data from its in-human VenoValve study showed that the first five patients observed displayed improvements in all study endpoints. Principal investigator Dr. Jorge Hernando Ulloa reported that the patients showed 10% improvement in reflux, 2% improvement in disease manifestations (VCSS scores) and 13% improvements in pain (VAS scores) […]
Abiomed touts real-world data on right-side heart failure with Impella RP
Abiomed (NSDQ:ABMD) said today that real-world data on its Impella RP heart pump showed a survival rate that matched that of its pre-approval study when following the FDA’s approved protocol for the device. The Impella RP is designed to treat right heart failure or decompensation following left ventricular assist device implantation, myocardial infarction, heart transplant, or […]
- 1
- 2
- 3
- …
- 181
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube